Related Experiment Video
Updated: Jul 4, 2026

Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology
Published on: March 27, 2018
Stem-cell approaches for kidney repair: choosing the right cells
Costanza Sagrinati1, Elisa Ronconi, Elena Lazzeri
1Excellence Center for Research, Transfer and High Education DENOthe (De Novo Therapies), University of Florence, V. le Morgagni 85, 50134, Florence, Italy.
Abstract:
With the increasing rate of end-stage renal failure and limited alternatives for its treatment, stem cell (SC) therapy for kidney injury is urgently needed. Choosing the right SC type is the critical step in realizing the potential of this therapeutic approach. Four possible sources of SCs are envisioned for the development of this type of treatment: (i) bone-marrow-derived SCs (BMSCs), (ii) renal adult SCs, (iii) embryonic SCs and (iv) fetal renal SCs. We suggest that resident SCs recently identified in the Bowman's capsule of adult human kidneys might prospectively be the ideal cell type for treatment of both acute and chronic renal injury because they display the potential to differentiate into multiple types of renal cells. However, BMSCs also represent an attractive alternative, especially for the treatment of patients affected by acute renal failure.
Insights
Stem cell therapy offers hope for kidney injury, with resident kidney stem cells (SCs) potentially ideal for treating acute and chronic renal failure. Bone-marrow-derived stem cells (BMSCs) are also a promising option, particularly for acute renal failure.
Area of Science:
- Regenerative Medicine
- Nephrology
- Stem Cell Biology
Background:
- Rising rates of end-stage renal failure necessitate novel therapeutic strategies.
- Limited treatment options exist for kidney injury, highlighting the need for advanced interventions.
- Stem cell (SC) therapy is a promising avenue for kidney repair and regeneration.
Purpose of the Study:
- To evaluate potential stem cell (SC) sources for kidney injury treatment.
- To identify the most suitable SC type for acute and chronic renal failure.
- To explore the therapeutic potential of resident kidney stem cells and bone-marrow-derived stem cells (BMSCs).
Main Methods:
- Review and analysis of four potential SC sources: bone-marrow-derived SCs (BMSCs), renal adult SCs, embryonic SCs, and fetal renal SCs.
- Identification and characterization of resident SCs in adult human kidneys.
- Assessment of SC differentiation potential into various renal cell types.
Main Results:
- Resident SCs identified in the Bowman's capsule of adult human kidneys show potential for differentiation into multiple renal cell types.
- These resident SCs are suggested as an ideal cell type for treating both acute and chronic renal injury.
- Bone-marrow-derived SCs (BMSCs) are identified as an attractive alternative, particularly for acute renal failure cases.
Conclusions:
- Resident kidney stem cells represent a highly promising candidate for regenerative therapy in kidney diseases.
- BMSCs offer a viable alternative for specific applications, such as acute renal failure.
- Further research into SC selection and application is critical for advancing kidney injury treatment.
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Stem Cell Culture
Kidney Transplant I: Introduction
iPS Cell Differentiation
Embryonic Stem Cells
Embryonic Stem Cells
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...

